IDEXX Laboratories
IDXX
Delayed Nasdaq - 06/18 10:00:00 pm
226.25USD
-0.72%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20172018
Sales1 9692 229
EBITDA496584
Operating profit (EBIT)413492
Pre-Tax Profit (EBT)--
Net income263367
EPS ( $ )2,944,14
Dividend per Share ( $ )--
Yield--
Announcement Date02/01/2018
11:44am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20172018
Debt789780
Finance--
Operating income (EBITDA)496584
Leverage
(Debt/EBITDA)
1,59x1,34x
Capital Expenditure74,4122
Book Value Per Share (BVPS)-0,62 $0,05 $
Cash Flow per Share4,17 $5,93 $
Announcement Date02/01/2018
11:44am
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 19 796 M$ -
Entreprise Value (EV) 20 576 M$ 20 365 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 55,0x 46,9x
Capitalization / Revenue 8,88x 8,06x
EV / Revenue 9,23x 8,29x
EV / EBITDA 35,3x 30,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 4 901x 270x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 22,1% 23,1%
operating Leverage (Delta EBIT / Delta Sales) 1,44x 1,53x
Net Margin (Net Profit / Revenue) 16,5% 17,3%
ROA (Net Profit / Asset) 33,5% 34,9%
ROE (Net Profit / Equities) 969% -784%
Rate of Dividend - -
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   5,45% 4,36%
Cash Flow / Sales 23,1% 23,7%
Capital Intensity (Assets / Sales) 0,49x 0,50x
Financial Leverage (Net Debt / EBITDA) 1,34x 0,86x
Price Earning Ratio
BNA & Dividende